Early post-operative opioid fills after cancer-directed surgery among Medicare beneficiaries by race and ethnicity.

1594 Background: Post-operative pain is often underestimated and undertreated. Researchers have shown that Black patients receive fewer opioids than White patients across multiple settings and conditions; however, little is known about whether post-operative opioid prescribing for cancer-directed surgery differs by race and ethnicity. We characterized racial and ethnic differences in opioid fills among Medicare beneficiaries undergoing cancer-directed surgery. Methods: Using 100% Medicare data for fee-for-service beneficiaries enrolled in parts A, B, and D, we identified episodes of cancer-directed surgeries from 2012-2021 among adults who survived > 30d after surgery and were discharged home. We used Part D claims to identify opioid prescriptions filled in the 30d after outpatient surgeries and the 30d after hospital discharge for inpatient surgeries, overall and among non-Hispanic White (NHW), Black (NHB), Hispanic, and Asian patients. Results: Among 981,702 surgical episodes (mean age 73 [SD 8] years, 36% male), 83% were NHW, 8% NHB, 4% Hispanic and 2% Asian patients. Most surgeries were for breast (38%), colorectal (15%), prostate (13%), or lung (10%) cancers. Most (67%) patients with surgical episodes had an opioid fill within 30d, with a mean dose of 246 morphine milligram equivalents (MMEs) in the first prescription, and a mean total dose of 360 MMEs filled within 30d of surgery or discharge. On average, patients filled 1.4 opioid prescriptions, with a mean of 9-days’ supply in the 30d after surgery or discharge. NHB patients had the highest rate of opioid prescription, doses, and days’ supply; Asian patients had the lowest rate of opioid prescriptions, doses, and days’ supply (Table). Findings among Hispanic patients mirrored NHW patients. Conclusions: Among Medicare beneficiaries undergoing cancer-directed surgeries in 2012-2021, two-thirds of surgical episodes were associated with an opioid fill. In contrast to prior studies of opioid fills among cancer patients, we observed the highest opioid fills among Black patients. Future work is needed to understand the association of time and patient, physician, and healthcare factors on post-operative opioid prescribing and to understand the association of opioid prescribing with pain control. Outcome in 30dMean (SD) Overall(n=981702) NHW(n=815966) NHB(n=77932) Hispanic(n=42663) Asian(n=21087) Filling an opioidn (%) 653883 (67%) 538183 (66%) 58323 (75%) 28866 (68%) 12937 (61%) MME, first prescription 246 (320) 245 (318) 271 (350) 243 (318) 211 (210) Total MME in 30d 360 (566) 356 (563) 420 (620) 358.9 (565) 276 (374) # of fills 1.4 (0.8) 1.4 (0.8) 1.5 (0.8) 1.4 (0.8) 1.3 (0.6) Days prescribed 9 (9) 9 (9) 10 (10) 9 (9) 8 (7) MME=morphine milligram equivalents.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2025-05-28
DOI
https://doi.org/10.1200/jco.2025.43.16_suppl.1594
Primary Topic
Pain Management and Opioid Use
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early post-operative opioid fills after cancer-directed surgery among Medicare beneficiaries by race and ethnicity.

Pang-Hsiang Liu, Alexi A. Wright, Ashley Odai-Afotey, Inga Van Wieren et al.
Journal of Clinical Oncology
Pain Management and Opioid Use
article

Early post-operative opioid fills after cancer-directed surgery among Medicare beneficiaries by race and ethnicity.

Pang-Hsiang Liu, Alexi A. Wright, Ashley Odai-Afotey, Inga Van Wieren, Mary Beth Landrum, Andrea C. Enzinger, Nancy L. Keating, Xu Wang
article en

Abstract

1594 Background: Post-operative pain is often underestimated and undertreated. Researchers have shown that Black patients receive fewer opioids than White patients across multiple settings and conditions; however, little is known about whether post-operative opioid prescribing for cancer-directed surgery differs by race and ethnicity. We characterized racial and ethnic differences in opioid fills among Medicare beneficiaries undergoing cancer-directed surgery. Methods: Using 100% Medicare data for fee-for-service beneficiaries enrolled in parts A, B, and D, we identified episodes of cancer-directed surgeries from 2012-2021 among adults who survived > 30d after surgery and were discharged home. We used Part D claims to identify opioid prescriptions filled in the 30d after outpatient surgeries and the 30d after hospital discharge for inpatient surgeries, overall and among non-Hispanic White (NHW), Black (NHB), Hispanic, and Asian patients. Results: Among 981,702 surgical episodes (mean age 73 [SD 8] years, 36% male), 83% were NHW, 8% NHB, 4% Hispanic and 2% Asian patients. Most surgeries were for breast (38%), colorectal (15%), prostate (13%), or lung (10%) cancers. Most (67%) patients with surgical episodes had an opioid fill within 30d, with a mean dose of 246 morphine milligram equivalents (MMEs) in the first prescription, and a mean total dose of 360 MMEs filled within 30d of surgery or discharge. On average, patients filled 1.4 opioid prescriptions, with a mean of 9-days’ supply in the 30d after surgery or discharge. NHB patients had the highest rate of opioid prescription, doses, and days’ supply; Asian patients had the lowest rate of opioid prescriptions, doses, and days’ supply (Table). Findings among Hispanic patients mirrored NHW patients. Conclusions: Among Medicare beneficiaries undergoing cancer-directed surgeries in 2012-2021, two-thirds of surgical episodes were associated with an opioid fill. In contrast to prior studies of opioid fills among cancer patients, we observed the highest opioid fills among Black patients. Future work is needed to understand the association of time and patient, physician, and healthcare factors on post-operative opioid prescribing and to understand the association of opioid prescribing with pain control. Outcome in 30dMean (SD) Overall(n=981702) NHW(n=815966) NHB(n=77932) Hispanic(n=42663) Asian(n=21087) Filling an opioidn (%) 653883 (67%) 538183 (66%) 58323 (75%) 28866 (68%) 12937 (61%) MME, first prescription 246 (320) 245 (318) 271 (350) 243 (318) 211 (210) Total MME in 30d 360 (566) 356 (563) 420 (620) 358.9 (565) 276 (374) # of fills 1.4 (0.8) 1.4 (0.8) 1.5 (0.8) 1.4 (0.8) 1.3 (0.6) Days prescribed 9 (9) 9 (9) 10 (10) 9 (9) 8 (7) MME=morphine milligram equivalents.

Journal of Clinical OncologyVol. 43(16_suppl)
Harvard University (US), Dana-Farber Cancer Institute (US)
Openalex Percentile: Top 79%
Pain Management and Opioid Use
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.